Ellsworth Growth and Income Fund had another solid quarter as the NAV was up 12.2%, outperforming the ICE BAML All Convertibles Index, which was up 8.9%.

Bancroft Fund had a strong quarter with the NAV up 12.4%, outperforming the ICE BAML All Convertibles Index, which was up 8.9 ...

Sterling Financial Holdings Company Plc has projected gross earnings of N149.27 billion for the fourth quarter ending December 31, 2025.The firm said the projection builds on the Group's performance ...

MindWalk Holdings Corp.™ ("MindWalk™", "Company", "we" or "us") (NASDAQ: HYFT), a Bio-Native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced ...

Normal’s financial condition remains positive with a strong revenue stream and property tax base and future expenses tracking at or below budget expectations.

Sterling Financial Holdings Company Plc ('Sterling HoldCo' or 'the Group') has sustained its growth momentum, projecting gross earnings of N149.27 billion for the fourth quarter ending December 31, ...

Attorney Cheryl Arakaki joins producer/host Coralie Chun Matayoshi to discuss what is child support and how it is determined, ...

KBRA assigns a rating of BBB- with a Stable Outlook to the subordinated notes issued by QCR Holdings, Inc. (NASDAQ: QCRH) ("the company"). The notes consist of two subordinated debt offerings: ...

This release contains a headline correction from the previous publication.Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15, ...

Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational ...

Bank of America has announced senior leadership appointments to further build and deliver its capabilities around the globe ...

Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational on ...